IECURE

Serial Number 97205517
Registration 6968830
700

Registration Progress

Application Filed
Jan 6, 2022
Under Examination
Approved for Publication
Nov 15, 2022
Published for Opposition
Nov 15, 2022
Registered
Jan 31, 2023

Trademark Image

IECURE

Basic Information

Serial Number
97205517
Registration Number
6968830
Filing Date
January 6, 2022
Registration Date
January 31, 2023
Published for Opposition
November 15, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 31, 2023
Registration
Registered
Classes
042

Rights Holder

Iecure, Inc.

03
Address
620 West Germantown Pike
Plymouth Metting, PA 19462

Ownership History

Iecure, Inc.

Original Applicant
03
Plymouth Metting, PA

Iecure, Inc.

Owner at Publication
03
Plymouth Metting, PA

Iecure, Inc.

Original Registrant
03
Plymouth Metting, PA

Legal Representation

Attorney
Brent R. Bellows

USPTO Deadlines

Next Deadline
1101 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230131)
Due Date
January 31, 2029
Grace Period Ends
July 31, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

11 events
Date Code Type Description Documents
Jan 31, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 31, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 13, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 12, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 13, 2022 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jan 13, 2022 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jan 10, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 10, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of of gene therapy, namely the research and development of gene therapy pharmaceutical compositions for use in treating genetic disorders in human patients by targeting gene insertion into the liver
First Use Anywhere: Feb 9, 2021
First Use in Commerce: Feb 9, 2021

Additional Information

Translation
The English translation of "Iecur" in the mark is "Liver".

Classification

International Classes
042